WisdomTree BioRevolution Fund

Rentabilität für sechs Monate: -18.03%
Industrie: Health & Biotech Equities

Kategorie	Aktie, %	Menge
Healthcare	79.10175	66
Materials	5.42128	6
Consumer Staples	3.63966	4
Consumer Discretionary	0.54998	1

Austausch	Aktie, %	Menge
NASDAQ	66.23	51
New York Stock Exchange	29.87	23
Tokyo Stock Exchange	2.6	2
XETRA Stock Exchange	1.3	1

Teilen nach Land

Land	Menge	Unternehmen
United States	66	Twist Bioscience Corporation (aktie - 3.5%) Natera, Inc. (aktie - 2.79%) Geron Corporation (aktie - 2.59%) Eli Lilly and Company (aktie - 2.46%) Agios Pharmaceuticals, Inc. (aktie - 2.35%) Blueprint Medicines Corporation (aktie - 2.21%) Vericel Corporation (aktie - 1.94%) Iovance Biotherapeutics, Inc. (aktie - 1.89%) Veracyte, Inc. (aktie - 1.83%) Ultragenyx Pharmaceutical Inc. (aktie - 1.67%) BridgeBio Pharma, Inc. (aktie - 1.62%) Fate Therapeutics (aktie - 1.61%) United Therapeutics Corporation (aktie - 1.59%) Alnylam Pharmaceuticals, Inc. (aktie - 1.56%) Regeneron (aktie - 1.55%) Sarepta Therapeutics, Inc. (aktie - 1.51%) Vertex (aktie - 1.5%) Myriad Genetics, Inc. (aktie - 1.47%) Amgen (aktie - 1.45%) Danaher Corporation (aktie - 1.44%) Novan, Inc. (aktie - 1.4%) Catalent (aktie - 1.39%) DuPont (aktie - 1.31%) Amicus Therapeutics, Inc. (aktie - 1.3%) Exact Sciences Corporation (aktie - 1.24%) Zoetis (aktie - 1.24%) Ionis Pharmaceuticals (aktie - 1.23%) Thermo Fisher Scientific (aktie - 1.22%) Stoke Therapeutics, Inc. (aktie - 1.22%) NeoGenomics, Inc. (aktie - 1.18%) Tyson Foods (aktie - 1.16%) Merck & Co (aktie - 1.16%) Johnson & Johnson (aktie - 1.15%) Agilent Technologies (aktie - 1.14%) Gilead Sciences (aktie - 1.13%) Beam Therapeutics Inc. (aktie - 1.1%) Dow Chemical (aktie - 1.08%) Corteva (aktie - 1.07%) Darling Ingredients Inc. (aktie - 1.04%) Bio-Techne Corporation (aktie - 1.01%) Illumina (aktie - 1%) Bristol-Myers (aktie - 0.9941%) Repligen Corporation (aktie - 0.9645%) Arcturus Therapeutics Holdings Inc. (aktie - 0.9091%) PFIZER (aktie - 0.8749%) Archer Daniels Midland (aktie - 0.8548%) Bio-Rad Laboratories (aktie - 0.8431%) Arrowhead Pharmaceuticals, Inc. (aktie - 0.7871%) Biogen (aktie - 0.7799%) BioMarin Pharmaceutical (aktie - 0.7732%) REGENXBIO (aktie - 0.7434%) Schrödinger, Inc. (aktie - 0.7211%) FMC Corporation (aktie - 0.681%) Intellia Therapeutics, Inc. (aktie - 0.6725%) Editas Medicine, Inc. (aktie - 0.6354%) Allogene Therapeutics (aktie - 0.6286%) Beyond Meat (aktie - 0.5809%) Green Plains Inc. (aktie - 0.5549%) Caribou Biosciences, Inc. (aktie - 0.5112%) 10x Genomics, Inc. (aktie - 0.4916%) Moderna (aktie - 0.4694%) Sana Biotechnology, Inc. (aktie - 0.4467%) Verve Therapeutics, Inc. (aktie - 0.4438%) Absci Corporation (aktie - 0.2797%) Precigen, Inc. (aktie - 0.2413%) Pacific Biosciences of California, Inc. (aktie - 0.1836%)
United Kingdom	1	AstraZeneca PLC (aktie - 1.16%)
Switzerland	1	CRISPR Therapeutics AG (aktie - 1.13%)
Netherlands	1	Qiagen N.V. (aktie - 1.12%)
Germany	3	BioNTech SE (aktie - 1.06%) Bayer AG (aktie - 0.8707%) CureVac N.V. (aktie - 0.3873%)
Denmark	1	Genmab A/S (aktie - 1.02%)
Japan	2	Takeda Pharmaceutical Company Limited (aktie - 0.9357%) Takara Bio Inc. (aktie - 0.3958%)
Canada	1	Nutrien Ltd. (aktie - 0.7176%)
Singapore	1	Genius Group Limited (aktie - 0.55%)

Bezahlen Sie Ihr Abonnement

Weitere Funktionen und Daten zur Unternehmens- und Portfolioanalyse sind im Abonnement verfügbar

Abonnieren

Aktie

Werkzeuge

Gemeinschaft

Kontakte

2025 © Investing Port
Kontakte | Werbung
Die Verwendung von porti.ru-Materialien ist nur zulässig, wenn ein aktiver indizierter Link zur Quelle vorhanden ist.